Legis Daily

SALTS Act

USA115th CongressS-207| Senate 
| Updated: 6/19/2018
Amy Klobuchar

Amy Klobuchar

Democratic Senator

Minnesota

Cosponsors (17)
Jeanne Shaheen (Democratic)Margaret Wood Hassan (Democratic)Dianne Feinstein (Democratic)Thomas Tillis (Republican)Edward J. Markey (Democratic)Christopher A. Coons (Democratic)Orrin G. Hatch (Republican)Mark R. Warner (Democratic)Lindsey Graham (Republican)Sheldon Whitehouse (Democratic)John Kennedy (Republican)Tina Smith (Democratic)John Cornyn (Republican)Chuck Grassley (Republican)Marco Rubio (Republican)John Hoeven (Republican)Richard Blumenthal (Democratic)

Judiciary Committee, Criminal Justice and Counterterrorism Subcommittee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Synthetic Abuse and Labeling of Toxic Substances Act of 2017 or the SALTS Act (Sec. 2) This bill amends the Controlled Substances Act to set forth factors that may be considered as evidence to determine whether a controlled substance analogue is intended for human consumption. (Under current law, a controlled substance analogue that is intended for human consumption is treated as a schedule I controlled substance. A schedule I controlled substance is a drug, substance, or chemical that: has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.)

Bill Text Versions

View Text
2 versions available

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jan 24, 2017
Introduced in Senate
Jan 24, 2017
Read twice and referred to the Committee on the Judiciary.
Apr 11, 2018
Committee on the Judiciary Subcommittee on Crime and Terrorism. Hearings held.
May 24, 2018
Committee on the Judiciary. Ordered to be reported without amendment favorably.
Jun 19, 2018
Committee on the Judiciary. Reported by Senator Grassley without amendment. Without written report.
Jun 19, 2018
Placed on Senate Legislative Calendar under General Orders. Calendar No. 472.
  • January 24, 2017
    Introduced in Senate


  • January 24, 2017
    Read twice and referred to the Committee on the Judiciary.


  • April 11, 2018
    Committee on the Judiciary Subcommittee on Crime and Terrorism. Hearings held.


  • May 24, 2018
    Committee on the Judiciary. Ordered to be reported without amendment favorably.


  • June 19, 2018
    Committee on the Judiciary. Reported by Senator Grassley without amendment. Without written report.


  • June 19, 2018
    Placed on Senate Legislative Calendar under General Orders. Calendar No. 472.

Crime and Law Enforcement

Related Bills

  • HR 115-6047: To amend the Controlled Substances Act relating to controlled substance analogues.
  • HR 115-2851: SITSA Act
Drug, alcohol, tobacco useDrug trafficking and controlled substancesEvidence and witnessesMarketing and advertising

SALTS Act

USA115th CongressS-207| Senate 
| Updated: 6/19/2018
Synthetic Abuse and Labeling of Toxic Substances Act of 2017 or the SALTS Act (Sec. 2) This bill amends the Controlled Substances Act to set forth factors that may be considered as evidence to determine whether a controlled substance analogue is intended for human consumption. (Under current law, a controlled substance analogue that is intended for human consumption is treated as a schedule I controlled substance. A schedule I controlled substance is a drug, substance, or chemical that: has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.)

Bill Text Versions

View Text
2 versions available

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jan 24, 2017
Introduced in Senate
Jan 24, 2017
Read twice and referred to the Committee on the Judiciary.
Apr 11, 2018
Committee on the Judiciary Subcommittee on Crime and Terrorism. Hearings held.
May 24, 2018
Committee on the Judiciary. Ordered to be reported without amendment favorably.
Jun 19, 2018
Committee on the Judiciary. Reported by Senator Grassley without amendment. Without written report.
Jun 19, 2018
Placed on Senate Legislative Calendar under General Orders. Calendar No. 472.
  • January 24, 2017
    Introduced in Senate


  • January 24, 2017
    Read twice and referred to the Committee on the Judiciary.


  • April 11, 2018
    Committee on the Judiciary Subcommittee on Crime and Terrorism. Hearings held.


  • May 24, 2018
    Committee on the Judiciary. Ordered to be reported without amendment favorably.


  • June 19, 2018
    Committee on the Judiciary. Reported by Senator Grassley without amendment. Without written report.


  • June 19, 2018
    Placed on Senate Legislative Calendar under General Orders. Calendar No. 472.
Amy Klobuchar

Amy Klobuchar

Democratic Senator

Minnesota

Cosponsors (17)
Jeanne Shaheen (Democratic)Margaret Wood Hassan (Democratic)Dianne Feinstein (Democratic)Thomas Tillis (Republican)Edward J. Markey (Democratic)Christopher A. Coons (Democratic)Orrin G. Hatch (Republican)Mark R. Warner (Democratic)Lindsey Graham (Republican)Sheldon Whitehouse (Democratic)John Kennedy (Republican)Tina Smith (Democratic)John Cornyn (Republican)Chuck Grassley (Republican)Marco Rubio (Republican)John Hoeven (Republican)Richard Blumenthal (Democratic)

Judiciary Committee, Criminal Justice and Counterterrorism Subcommittee

Crime and Law Enforcement

Related Bills

  • HR 115-6047: To amend the Controlled Substances Act relating to controlled substance analogues.
  • HR 115-2851: SITSA Act
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Drug, alcohol, tobacco useDrug trafficking and controlled substancesEvidence and witnessesMarketing and advertising